Mentor Plans Expansion Of Prevelle Dermal Filler Line, Strategic Review
This article was originally published in The Gray Sheet
Executive Summary
New additions to Mentor's fledgling Prevelle dermal filler portfolio in the U.S. will help grow its facial aesthetic product revenue in the next several years, the company said during a Nov. 5 second-quarter earnings call
You may also be interested in...
J&J Adds Aesthetics To Ethicon With $1.07 Billion Mentor Acquisition
Johnson & Johnson will take control of about half of the worldwide breast implant market and gain liposuction and body contour surgery products with its $1.07 billion acquisition of Mentor
J&J Adds Aesthetics To Ethicon With $1.07 Billion Mentor Acquisition
Johnson & Johnson will take control of about half of the worldwide breast implant market and gain liposuction and body contour surgery products with its $1.07 billion acquisition of Mentor
FDA Dermal Fillers Panel Calls For Larger Clinical Trials Focused On Safety
FDA's General and Plastic Surgery Devices advisory panel called for larger, safety-focused pre-market clinical trials for future aesthetic facial dermal filler products